| 000 | 01777 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250512002725.0 | ||
| 264 | 0 | _c19890718 | |
| 008 | 198907s 0 0 eng d | ||
| 022 | _a0902-4441 | ||
| 024 | 7 |
_a10.1111/j.1600-0609.1989.tb01469.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorra, E | |
| 245 | 0 | 0 |
_aBone marrow and blood involvement by non-Hodgkin's lymphoma: a study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation. _h[electronic resource] |
| 260 |
_bEuropean journal of haematology _cMay 1989 |
||
| 300 |
_a445-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aActuarial Analysis |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aLazzarino, M | |
| 700 | 1 | _aCastello, A | |
| 700 | 1 | _aInverardi, D | |
| 700 | 1 | _aCoci, A | |
| 700 | 1 | _aPagnucco, G | |
| 700 | 1 | _aOrlandi, E | |
| 700 | 1 | _aMerante, S | |
| 700 | 1 | _aMagrini, U | |
| 700 | 1 | _aZei, G | |
| 773 | 0 |
_tEuropean journal of haematology _gvol. 42 _gno. 5 _gp. 445-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.1989.tb01469.x _zAvailable from publisher's website |
| 999 |
_c2477658 _d2477658 |
||